Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,218 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 452
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +2.6%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 101–150 of 228 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06029998	Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion(BORXPTEN)	active not recruiting	Phase 2	22	University of UtahOTHER	1	Jul 7, 2026	clinicaltrials
NCT06526299	Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease	recruiting	Phase 2	51	University of WashingtonOTHER	1	Jul 7, 2026